Clinical Effects of Recently Developed Antipsychotic Drugs in Schizophrenia

Key Points

• New antipsychotic drugs exhibit therapeutic effects superior to second-generation options, indicating potential benefits for treatment.
• Phase 3 clinical studies have confirmed the effectiveness of various newly developed antipsychotic drugs in managing symptoms of schizophrenia.
• The assessment includes drugs like cariprazine, brexpiprazole, lumateperone, ulotaront, and xanomeline combined with trospium.
• This research highlights the need for innovative treatment approaches in schizophrenia management.

Abstract